Investing News Why Did Jounce Therapeutics (JNCE) Stock Gain 72% Today? Following an amendment in a strategic agreement, shares of Jounce Therapeutics Inc. (JNCE) increased 59.75% to $1.18 on Wednesday. Which agreement has JNCE amended? In